(Q36970329)

17 August 2017

1 reference

title

Alterations in energy metabolism in cardiomyopathies (English)

1 reference

17 August 2017

Maysa Taha

1

1 reference

PubMed ID

17934906

17 August 2017

Gary D Lopaschuk

series ordinal

2

1 reference

PubMed ID

17934906

17 August 2017

language of work or name

English

0 references

publication date

1 January 2007

1 reference

17 August 2017

1 reference

17 August 2017

39

1 reference

17 August 2017

594-607

1 reference

17 August 2017

8

1 reference

Cost-effectiveness analysis in clinical practice: the case of heart failure

17 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions. Potential for pharmacological interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Myocardial substrate metabolism in the normal and failing heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Is the failing heart energy starved? On using chemical energy to support cardiac function

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Some aspects of foetal and uteroplacental metabolism in cows with indwelling umbilical and uterine vascular catheters

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

The role of lactate as an energy substrate for the brain during the early neonatal period

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Changes in mitochondrial respiratory chain proteins during perinatal development. Evidence of the importance of environmental oxygen tension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Postnatal development of palmitate oxidation and mitochondrial enzyme activities in rat cardiac and skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Routes of FA delivery to cardiac muscle: modulation of lipoprotein lipolysis alters uptake of TG-derived FA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Cardiac fatty acid uptake and transport in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Long-chain fatty acid uptake and FAT/CD36 translocation in heart and skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Fatty acid import into mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Regulation of fatty acid oxidation in the mammalian heart in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

PPAR signaling in the control of cardiac energy metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

The role of the peroxisome proliferator-activated receptor alpha pathway in pathological remodeling of the diabetic heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Peroxisome proliferator-activated receptor alpha (PPARalpha) signaling in the gene regulatory control of energy metabolism in the normal and diseased heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Nuclear receptor signaling and cardiac energetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Myocardial substrate utilization during exercise in humans. Dual carbon-labeled carbohydrate isotope experiments

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Metabolic fate of extracted glucose in normal human myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Effects of acute hyperglycemia on myocardial glycolytic activity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Regulation of cardiac long-chain fatty acid and glucose uptake by translocation of substrate transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Role of the nitric oxide pathway in AMPK-mediated glucose uptake and GLUT4 translocation in heart muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Insulin and contraction stimulate exocytosis, but increased AMP-activated protein kinase activity resulting from oxidative metabolism stress slows endocytosis of GLUT4 in cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase: head-to-head with a bifunctional enzyme that controls glycolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Role of fructose 2,6-bisphosphate in the control of glycolysis in mammalian tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Utilization of energy-providing substrates in the isolated working rat heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Decreased insulin binding, glucose transport, and glucose metabolism in soleus muscle of rats fed a high fat diet.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Involvement of protein kinase C in human skeletal muscle insulin resistance and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

A molecular basis for insulin resistance. Elevated serine/threonine phosphorylation of IRS-1 and IRS-2 inhibits their binding to the juxtamembrane region of the insulin receptor and impairs their ability to undergo insulin-induced tyrosine phosphory

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Evidence for existence of tissue-specific regulation of the mammalian pyruvate dehydrogenase complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Starvation and diabetes increase the amount of pyruvate dehydrogenase kinase isoenzyme 4 in rat heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Regulation of pyruvate dehydrogenase in rat heart. Mechanism of regulation of proportions of dephosphorylated and phosphorylated enzyme by oxidation of fatty acids and ketone bodies and of effects of diabetes: role of coenzyme A, acetyl-coenzyme A a

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Active and inactive forms of pyruvate dehydrogenase in rat heart and kidney: effect of diabetes, fasting, and refeeding on pyruvate dehydrogenase interconversion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Fuel selection in animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Control of the tricarboxylate cycle and its interactions with glycolysis during acetate utilization in rat heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Glucose and glycogen utilisation in myocardial ischemia--changes in metabolism and consequences for the myocyte

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Effects of pH on the myofilaments and the sarcoplasmic reticulum of skinned cells from cardiace and skeletal muscles

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

The role of the myocardial sodium-hydrogen exchanger in mediating ischemic and reperfusion injury. From amiloride to cariporide

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Contribution of protons to post-ischemic Na(+) and Ca(2+) overload and left ventricular mechanical dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Role of the cardiac Na+/H+ exchanger during ischemia and reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Intracellular Na+ regulation in cardiac myocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Integrated Ca2+ management in cardiac myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Acidosis during ischemia promotes adenosine triphosphate resynthesis in postischemic rat heart. In vivo regulation of 5'-nucleotidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Alterations of carbohydrate and lipid metabolism in the acutely ischemic heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Glucose metabolism distal to a critical coronary stenosis in a canine model of low-flow myocardial ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Alterations of the mitochondrial respiratory chain in human dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Electron transport chain defects in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Cardiac myosin binding protein-C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

First mutation in cardiac troponin C, L29Q, in a patient with hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Alpha-cardiac actin is a novel disease gene in familial hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Structural analysis of the titin gene in hypertrophic cardiomyopathy: identification of a novel disease gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Energy substrate metabolism in cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Regular exercise is associated with a protective metabolic phenotype in the rat heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

The AMP-activated protein kinase--fuel gauge of the mammalian cell?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Mutations in the gamma(2) subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Identification of a gene responsible for familial Wolff-Parkinson-White syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Transgenic mice overexpressing mutant PRKAG2 define the cause of Wolff-Parkinson-White syndrome in glycogen storage cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Transgenic mouse model of ventricular preexcitation and atrioventricular reentrant tachycardia induced by an AMP-activated protein kinase loss-of-function mutation responsible for Wolff-Parkinson-White syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

AMP-activated protein kinase: the energy charge hypothesis revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Regulation of 5'-AMP-activated protein kinase activity by the noncatalytic beta and gamma subunits

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Non-catalytic beta- and gamma-subunit isoforms of the 5'-AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Synergy in protein engineering. Mutagenic manipulation of protein structure to simplify semisynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Identification of a novel AMP-activated protein kinase beta subunit isoform that is highly expressed in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Characterization of AMP-activated protein kinase gamma-subunit isoforms and their role in AMP binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

AMP-activated protein kinase isoenzyme family: subunit structure and chromosomal location

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

AMPK alterations in cardiac physiology and pathology: enemy or ally?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Characterization of the role of gamma2 R531G mutation in AMP-activated protein kinase in cardiac hypertrophy and Wolff-Parkinson-White syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

N488I mutation of the gamma2-subunit results in bidirectional changes in AMP-activated protein kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Diabetes and cardiovascular disease. The Framingham study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Diabetes mellitus and coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Diabetes mellitus and congestive heart failure. Further knowledge needed

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Diabetic cardiomyopathy: recent evidence from mouse models of type 1 and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Myocardial substrate metabolism: implications for diabetic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Alteration in haemodynamics and pathological changes in the cardiovascular system during the development of Type 2 diabetes mellitus in OLETF rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Diabetes-induced abnormalities in the myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Lipoprotein lipase (LpL) on the surface of cardiomyocytes increases lipid uptake and produces a cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Transgenic expression of fatty acid transport protein 1 in the heart causes lipotoxic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

A novel mouse model of lipotoxic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Lipotoxic heart disease in obese rats: implications for human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Free fatty acids repress the GLUT4 gene expression in cardiac muscle via novel response elements

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Effect of non-insulin-dependent diabetes mellitus on myocardial insulin responsiveness in patients with ischemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Myocardial insulin resistance associated with chronic hypertriglyceridemia and increased FFA levels in Type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Insulin resistance characterizes glucose uptake in skeletal muscle but not in the heart in NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Changes in fatty acid transport and transporters are related to the severity of insulin deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Metabolic effects of insulin on cardiomyocytes from control and diabetic db/db mouse hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Molecular mechanisms of inherited cardiomyopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Arrhythmogenic right ventricular cardiomyopathy. Dysplasia, dystrophy, or myocarditis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Arrhythmogenic right ventricular dysplasia/cardiomyopathy: need for an international registry. Study Group on Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy of the Working Groups on Myocardial and Pericardial Disease and Arrhythmias of th

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

New insights into the pathology of inherited cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Mitochondrial function in heart muscle from patients with idiopathic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

Citrate as an Intermediary in the Inhibition of Phosphofructokinase in Rat Heart Muscle by Fatty Acids, Ketone Bodies, Pyruvate, Diabetes and Starvation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701618305

10.1080/07853890701618305

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference

PubMed ID

17934906